|
|
||||||||
George M. O'Brien Kidney and Urological Disease Center, Renal Division, Departments of Medicine, Cell Biology, and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110
To delineate the roles that oxygen and fibroblast growth factors (FGFs) play in the process of angiogenesis from the embryonic aorta, we cultured mouse embryonic aorta explants (thoracic level to lateral vessels supplying the mesonephros and metanephros) in a three-dimensional type I collagen gel matrix. During 8 days of culture under 5% O2, but not room air, the addition of FGF2 to explants stimulated the formation of Gs-IB4-positive, CD31-positive, and Flk-1-positive microvessels in a concentration-dependent manner. FGF2-stimulated microvessel formation was inhibited by sequestration of FGF2 via addition of soluble FGF receptor (FGFR) chimera protein or anti-FGF2 antibodies. FGFR1 and FGFR2 were present on explants. Levels of FGFR1, but not FGFR2, were increased in embryonic aorta cultured under 5% O2 relative to room air. Our data suggest that low oxygen upregulates FGFR1 expression in embryonic aorta in vitro and renders it more responsive to FGF2.
angiogenesis; embryogenesis; endothelial cell; organ culture
This article has been cited by other articles:
![]() |
C.A. Stein, S. Wu, A. M. Voskresenskiy, J.-F. Zhou, J. Shin, P. Miller, N. Souleimanian, and L. Benimetskaya G3139, an Anti-Bcl-2 Antisense Oligomer That Binds Heparin-Binding Growth Factors and Collagen I, Alters In vitro Endothelial Cell Growth and Tubular Morphogenesis Clin. Cancer Res., April 15, 2009; 15(8): 2797 - 2807. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Benimetskaya, S. Wu, A. M. Voskresenskiy, C. Echart, J.-F. Zhou, J. Shin, M. Iacobelli, P. Richardson, K. Ayyanar, and C. A. Stein Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease Blood, November 15, 2008; 112(10): 4343 - 4352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Little Regrow or Repair: Potential Regenerative Therapies for the Kidney J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2390 - 2401. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |